Oops. A 60MB source map file just leaked Anthropic's entire roadmap.
Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.
Court of King’s Bench Justice puts legal pause on the certification until she makes a ruling on the case brought forward by ...